# Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage

> **NCT06924983** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yong Jiang** · enrollment: 100 (estimated)

## Conditions studied

- Stroke
- Intracerebral Hemorrhage Basal Ganglia
- Methylprednisolone
- Surgery

## Interventions

- **PROCEDURE:** Simple neuroendoscopic hematoma evacuation
- **COMBINATION_PRODUCT:** Neuroendoscopic hematoma evacuation combined with sodium methylprednisolone succinate

## Key facts

- **NCT ID:** NCT06924983
- **Lead sponsor:** Yong Jiang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06924983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06924983, "Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06924983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*